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Dear Editor,
I read with the interest the paper by Jowkar et al. pub-
lished in a recent issue of Hepatitis Monthly (1). The 
authors analysed the frequency of two HFE gene muta-
tions in Iranian patients with a diagnosis of cryptogenic 
cirrhosis. In Europe, North America and Australia the 
homozygous C282Y mutation of the HFE gene is a major 
etiological factor associated with the pathogenesis of 
progressive iron accumulation leading to multiorgan 
disfunction, as it is observed in hereditary hemochroma-
tosis. About 5% of hereditary hemochromatosis cases in 
the Caucasian population are related to compound het-
erozygosity for C282Y and H63D mutations (2). The im-
pact of other HFE gene mutations on the development of 
iron overload is discussed (3). Despite the relatively high 
frequency of HFE  gene mutations among Caucasians, 
their phenotypic expression are limited and the causes 
of this are not fully identiﬁed. Moreover among Cauca-
sians, the frequency of HFE gene mutated alleles  is clear-
ly diﬀerentiated, which determines the real signiﬁcance 
of the mutations in the development of genetically de-
termined iron overload (2). In Polish patients with a diag-
nosis of liver cirrhosis, iron overload symptoms were ob-
served in 70% of cases and in this selected population the 
homozygous C282Y mutation appeared to occur more 
frequently in comparison to the healthy population (4). 
Jowkar et al. did not conﬁrm the association of HFE gene 
mutations with a diagnosis of cryptogenic cirrhosis in 
Iranian patients, which seems to lead to the erroneous 
conclusion that the HFE gene defect has no pathogenic 
signiﬁcance. The authors included mainly patients with-
out symptoms of iron overload (86%) in their study. They 
also did not describe how they assessed the patients’ iron 
status. The recruitment of only cryptogenic cirrhosis cas-
es means that iron overload patients suspected of heredi-
tary hemochromatosis were excluded. Thus the results of 
the study are not surprising, however they cannot serve 
as a complete source of information about the inﬂuence 
of the HFE gene mutations on the development of liver 
cirrhosis. In my opinion, in the discussion concerning 
the potential inﬂuence of HFE gene mutations on mor-
bidity, e.g. course of liver diseases, analysis of their occur-
rence should always be related to the presence of iron 
metabolism disturbances. An undeniable fact is that the 
increased risk of liver diseases (hepatocellular carcino-
ma, hepatitis C, non-alcoholic steatohepatitis) that was 
conﬁrmed in carriers of C282Y mutations, is a result of 214 Hepat Mon. 2012
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disturbed iron homeostasis caused by HFE protein dys-
function (5).
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